非典型抗精神病药物的代谢作用:分子点
Maria Fonseca1, Francisca Carmo2, Fátima Martel2,3
1Faculty of Medicine, University of Porto, Porto, Portugal.
Journal of neuroendocrinology
|October 22, 2023
概括
非典型抗精神病药 (AAPs) 可以引起代谢综合征 (MetS),其特点是高血压,血糖和胆固醇. 了解这些药物诱导的代谢变化是开发更安全治疗的关键.
科学领域:
- 药理学 药理学是指药理学的学科.
- 代谢医学是一种代谢医学.
- 神经科学是一个神经科学.
背景情况:
- 非典型抗精神病药 (AAP) 广泛用于精神分裂症和双相情感障碍.
- AAP可以导致代谢综合征 (MetS),增加2型糖尿病和心血管疾病的风险.
研究的目的:
- 审查AAP诱导的代谢异常背后的分子和细胞机制.
- 要突出AAP对荷尔蒙调节和代谢器官的影响的复杂性.
主要方法:
- 关于分子和细胞机制的文献综述.
- 分析AAP对关键代谢器官和系统的影响.
主要成果:
- AAPs影响多个细胞点,影响荷尔蒙和神经调节器.
- AAPs破坏肝脏,胰腺,脂肪组织,肌肉和神经系统的代谢功能.
结论:
- 需要进一步了解AAP-MetS链接.
- 这些知识可以指导开发具有较少副作用和有效辅助疗法的AAP.
相关概念视频
Antipsychotic Drugs: Typical and Atypical Agents
223
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
223
Antipsychotic Drugs: Therapeutic Uses and Side Effects
233
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
233
Psychosis and Antipsychotic Drugs: Overview
290
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
290
Antidepressant Drugs: MAOIs and Other Agents
254
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
254
Psychosis: Goals of Pharmacotherapy
145
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
145
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
696
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
696


